Skip to content

Efficacy Evaluation of Flap Repair After Wide Excision for Axillary Hidradenitis Suppurativa

Efficacy Evaluation of Flap Repair After Wide Excision for Axillary Hidradenitis Suppurativa

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125971
Enrollment
Unknown
Registered
2026-06-01
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hidradenitis suppurativa

Interventions

Observation group:None

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Clinically confirmed diagnosis of axillary hidradenitis suppurativa (HS) (Hurley stage II/III); 2.Undergoing bilateral extensive axillary excision (with resection extending to the deep fascial layer); 3.Postoperative skin defects repaired with flaps (any type of flap, e.g., local rotation flap, V-Y advancement flap, etc.); 4.Availability of complete preoperative, intraoperative, and postoperative follow-up records for at least 6 months (follow-up completed; study only retrospectively extracts relevant data); 5.Complete baseline data in the database, including age, sex, body mass index (BMI), smoking history, diabetes history, Hurley stage, resection area, etc.

Exclusion criteria

Exclusion criteria: 1.Postoperative defects managed by secondary intention healing, skin grafting, or other non-flap repair methods; 2.Patients who did not undergo extensive excisional surgery; 3.Loss to follow-up or incomplete follow-up data (follow-up duration less than 6 months post-surgery, or missing key follow-up information); 4.Long-term use of glucocorticoids or immunosuppressive agents; 5.Presence of other serious diseases that may affect wound healing (e.g., severe immunodeficiency, active malignancy, severe hepatic or renal dysfunction, severe malnutrition, etc.).

Design outcomes

Primary

MeasureTime frame
Postoperative recurrence rate;Wound healing time;

Secondary

MeasureTime frame
Work Productivity and Activity Impairment Questionnaire;Dermatology Life Quality Index;Incidence of postoperative complications;Simple Shoulder Test;Vancouver Scar Scale;

Countries

China

Contacts

Public ContactLiu Yang

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

bengpao82@163.com+86 27 8576 8188

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026